Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000000637 ◽

2017 ◽

Vol 38 (2) ◽

pp. 193-200 ◽

Author(s):

Xiaozhou Yu ◽

Yanjia Zhu ◽

Jian Wang ◽

Xiuyu Song ◽

Lei Zhu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell Lung ◽

Extensive Stage ◽

18F Fdg ◽

Line Chemotherapy

Download Full-text

Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy plus atezolizumab

Annals of Oncology ◽

10.1093/annonc/mdz264.006 ◽

2019 ◽

Vol 30 ◽

pp. v713 ◽

Author(s):

D. Daniel ◽

V. Kuchava ◽

I. Bondarenko ◽

O. Ivashchuk ◽

D. Spigel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-10-2791 ◽

2011 ◽

Vol 17 (15) ◽

pp. 5093-5100 ◽

Author(s):

Dok Hyun Yoon ◽

Sora Baek ◽

Chang-Min Choi ◽

Dae Ho Lee ◽

Cheolwon Suh ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Fdg Pet ◽

Small Cell Lung ◽

Potential Tool ◽

Line Chemotherapy

Download Full-text

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318207cd8b ◽

2011 ◽

Vol 6 (2) ◽

pp. 408

Author(s):

Jingwei Jiang ◽

Xiaohua Liang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-02926-3 ◽

2021 ◽

Author(s):

Wei-Xiang Qi ◽

Yi Xiang ◽

Shengguang Zhao ◽

Jiayi Chen

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Trilaciclib and the economic value of multilineage myeloprotection from chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer treated with first-line chemotherapy

Journal of Medical Economics ◽

10.1080/13696998.2021.2014163 ◽

2021 ◽

pp. 1-37

Author(s):

Ivo Abraham ◽

Uchenna Onyekwere ◽

Baris Deniz ◽

Donald Moran ◽

Marc Chioda ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Economic Value ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

P64.03 A Phase II Single-Arm Trial of Apatinib as Maintenance Treatment Following First-Line Chemotherapy in Extensive Stage Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.674 ◽

2021 ◽

Vol 16 (10) ◽

pp. S1190

Author(s):

F. Teng ◽

P. Xing ◽

Y. Wang ◽

X. Hu ◽

L. Lin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Maintenance Treatment ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)

Clinical Lung Cancer ◽

10.1016/j.cllc.2012.04.001 ◽

2013 ◽

Vol 14 (1) ◽

pp. 34-39 ◽

Author(s):

Martin Früh ◽

Richard Cathomas ◽

Marco Siano ◽

Gregor Tscherry ◽

Alfred Zippelius ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1888717 ◽

2021 ◽

pp. 1-7

Author(s):

Guoqiang Liu ◽

Shuo Kang

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Consolidative thoracic radiotherapy after first-line chemotherapy and immunotherapy in extensive-stage small cell lung cancer: a multi-institutional case series

Advances in Radiation Oncology ◽

10.1016/j.adro.2021.100883 ◽

2021 ◽

pp. 100883

Author(s):

Brett H. Diamond ◽

Nipun Verma ◽

Utkarsh C. Shukla ◽

Henry S. Park ◽

Paul P. Koffer

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Case Series ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text

Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdy298.002 ◽

2018 ◽

Vol 29 ◽

pp. viii597 ◽

Author(s):

K.H. Dragnev ◽

T.K. Owonikoko ◽

T. Csoszi ◽

M. Maglakelidze ◽

J.T. Beck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Extensive Stage ◽

Line Chemotherapy

Download Full-text